| Biosynthesis of unsaturated fatty acids |
-1.72 |
1.35e-2 |
21/27 (77.78%) |
ELOVL5;ELOVL2;HSD17B4;...
|
| Epithelial cell signaling in Helicobacter pylori infect... |
-1.73 |
1.32e-2 |
62/70 (88.57%) |
RELA;NFKB1;CHUK;...
|
| Measles |
-1.73 |
1.36e-2 |
133/139 (95.68%) |
CCND2;MAPK8;CDK4;...
|
| Cytokine-cytokine receptor interaction |
-1.74 |
1.28e-2 |
246/295 (83.39%) |
IL11;CCL16;IL36RN;...
|
| Retinol metabolism |
-1.76 |
1.14e-2 |
41/68 (60.29%) |
CYP26B1;ADH1C;CYP2C8;...
|
| B cell receptor signaling pathway |
-1.78 |
9.91e-3 |
71/81 (87.65%) |
LILRB2;INPPL1;IKBKB;...
|
| Colorectal cancer |
-1.79 |
9.81e-3 |
84/86 (97.67%) |
BCL2;TGFBR2;MAPK8;...
|
| Influenza A |
-1.82 |
5.39e-3 |
156/172 (90.7%) |
AKT1;RELA;KPNA6;...
|
| Lipid and atherosclerosis |
-1.85 |
3.94e-3 |
190/215 (88.37%) |
NLRP3;TANK;NFATC3;...
|
| Pancreatic cancer |
-1.86 |
4.13e-3 |
75/76 (98.68%) |
TGFBR2;MAPK8;CDK4;...
|
| AGE-RAGE signaling pathway in diabetic complications |
-1.87 |
2.48e-3 |
97/100 (97%) |
PIM1;BCL2;VEGFB;...
|
| Leishmaniasis |
-1.88 |
2.61e-3 |
67/77 (87.01%) |
NCF4;C3;HLA-DRA;...
|
| TGF-beta signaling pathway |
-1.88 |
2.75e-3 |
81/94 (86.17%) |
RPS6KB1;ID2;CDKN2B;...
|
| Osteoclast differentiation |
-1.90 |
2.92e-3 |
117/127 (92.13%) |
IFNB1;NCF4;SYK;...
|
| Hepatitis B |
-1.91 |
3.10e-3 |
151/162 (93.21%) |
TGFBR2;ATF2;MAPK8;...
|
| Kaposi sarcoma-associated herpesvirus infection |
-1.91 |
3.30e-3 |
172/193 (89.12%) |
EP300;MICB;IKBKB;...
|
| Primary bile acid biosynthesis |
-1.92 |
2.65e-3 |
15/17 (88.24%) |
SCP2;CYP46A1;ACOX2;...
|
| Toll-like receptor signaling pathway |
-1.96 |
1.91e-3 |
94/104 (90.38%) |
CD86;CXCL9;AKT1;...
|
| Complement and coagulation cascades |
-1.98 |
2.06e-3 |
76/85 (89.41%) |
C8B;PROC;C6;...
|
| PD-L1 expression and PD-1 checkpoint pathway in cancer |
-2.01 |
1.13e-3 |
79/89 (88.76%) |
IFNG;IKBKB;ALK;...
|
| Bladder cancer |
-2.03 |
1.24e-3 |
40/41 (97.56%) |
CDK4;RB1;MYC;...
|
| Viral protein interaction with cytokine and cytokine re... |
-2.06 |
0.00e+0 |
84/100 (84%) |
IL19;TNFRSF10C;TNFSF14;...
|
| Coronavirus disease |
-2.09 |
0.00e+0 |
215/232 (92.67%) |
RPS25;RPL6;RPS3;...
|
| NOD-like receptor signaling pathway |
-2.10 |
0.00e+0 |
145/181 (80.11%) |
MAPK8;CASR;IFNA17;...
|
| NF-kappa B signaling pathway |
-2.10 |
0.00e+0 |
90/104 (86.54%) |
SYK;TNFSF11;EDAR;...
|
| Malaria |
-2.15 |
0.00e+0 |
44/50 (88%) |
VCAM1;CD40LG;KLRB1;...
|
| Rheumatoid arthritis |
-2.15 |
0.00e+0 |
78/93 (83.87%) |
TNFSF11;CD86;HLA-DRA;...
|
| TNF signaling pathway |
-2.17 |
0.00e+0 |
103/112 (91.96%) |
AKT1;RELA;VCAM1;...
|
| C-type lectin receptor signaling pathway |
-2.21 |
0.00e+0 |
93/104 (89.42%) |
NLRP3;NFATC3;NFATC4;...
|
| IL-17 signaling pathway |
-2.38 |
0.00e+0 |
84/94 (89.36%) |
IL5;MMP1;RELA;...
|
